Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Cost-effectiveness of chronic hepatitis C screening and treatment

Hye Won Lee, Hankil Lee, Beom Kyung Kim, Young Chang, Jae Young Jang, Do Young Kim

Clin Mol Hepatol. 2022;28(2):164-173. Published online December 27, 2021

DOI: https://doi.org/10.3350/cmh.2021.0193

Original Article

The cut-off value of transient elastography to the value of hepatic venous pressure gradient in alcoholic cirrhosis

Se Ri Ryu, Jeong-Ju Yoo, Seong Hee Kang, Soung Won Jeong, Moon Young Kim, Young Kyu Cho, Young Chang, Sang Gyune Kim, Jae Young Jang, Young Seok Kim, Soon Koo Baik, Yong Jae Kim, Su Yeon Park, Baigal Baymbajav

Clin Mol Hepatol. 2021;27(1):197-206. Published online December 3, 2020

Cited By 3

DOI: https://doi.org/10.3350/cmh.2020.0171

Clinical application of ultrasonography-guided percutaneous liver biopsy and its safety over 18 years

Young Chang, Jun Il Kim, Bora Lee, Sang Gyune Kim, Min Jung Jung, Young Seok Kim, Soung Won Jeong, Jae Young Jang, Jeong-Ju Yoo

Clin Mol Hepatol. 2020;26(3):318-327. Published online May 25, 2020

Cited By 14

DOI: https://doi.org/10.3350/cmh.2019.0019n

1 |

Viewed By 7025	Association between serum tumor necrosis factor-α and sarcopenia in liver cirrhosis
Viewed By 4135	Letter: cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis
Viewed By 3618	KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Viewed By 2814	KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications
Viewed By 2041	Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop

Cited By 44	Trends in the prevalence of chronic liver disease in the Korean adult population, 1998–2017
Cited By 33	Application of transient elastography in nonalcoholic fatty liver disease
Cited By 30	Novel biomarkers for the management of chronic hepatitis B
Cited By 29	Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy
Cited By 29	Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop

Search